IKK2-IN-4

CAS No. 354811-10-2

IKK2-IN-4( —— )

Catalog No. M34854 CAS No. 354811-10-2

IKK2-IN-4(IKK2 Inhibitor VI) is a highly potent IKK-2 inhibitor with an IC50 value of 25 nM. IKK2-IN-4 inhibited the production of TNF-α in PBMC induced by LPS.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 276 In Stock
10MG 424 In Stock
25MG 656 In Stock
50MG 866 In Stock
100MG 1163 In Stock
200MG 1553 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    IKK2-IN-4
  • Note
    Research use only, not for human use.
  • Brief Description
    IKK2-IN-4(IKK2 Inhibitor VI) is a highly potent IKK-2 inhibitor with an IC50 value of 25 nM. IKK2-IN-4 inhibited the production of TNF-α in PBMC induced by LPS.
  • Description
    IKK2-IN-4 (compound 4) is a potent IKK-2 inhibitor, with an IC50 of 25 nM. IKK2-IN-4 can inhibit the LPS-induced production of TNFα in PBMCs.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    IκB kinase (IKK)
  • Recptor
    IκB/IKK | TNF
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    354811-10-2
  • Formula Weight
    261.3
  • Molecular Formula
    C12H11N3O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(C(N)=O)C=1SC(=CC1C(N)=O)C2=CC=CC=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Baxter A, et, al. Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors. Bioorg Med Chem Lett. 2004 Jun 7;14(11):2817-22.?
molnova catalog
related products
  • BMS-345541

    A potent and selective IKK-2 inhibitor with IC50 of 0.3 uM.

  • MRT67307 HCl

    MRT67307 is a kinase inhibitor of TBK1 MARK1-4 IKKε and NUAK1 (IC50: 19 27-52 160 and 230 nM respectively).

  • AZD3264

    A novel IkB-kinase IKK2 inhibitor for treatment of inflammatory conditions such as asthma, chronic pulmonary obstructive disorder (COPD) and rheumatoid arthritis.